Jonathan C Fox Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jonathan C Fox.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jonathan C Fox. Jonathan C Fox is Chief Medical Officer in MyoKardia Inc ($MYOK) and See Remarks in Eidos Therapeutics, Inc. ($EIDX).
Latest Insider Trading Transactions of Jonathan C Fox
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Option Exercise | D | 13.20 | 70,000 | 924,000 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | U | 0.00 | 380,467 | 0 | 0 | 380.5 K to 0 (-100.00 %) |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Gift | G | 0.00 | 500 | 0 | 380,467 | 381 K to 380.5 K (-0.13 %) |
Sep 18 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 50.16 | 5,767 | 289,259 | 377,673 | 383.4 K to 377.7 K (-1.50 %) |
Sep 16 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 50.16 | 3,122 | 156,610 | 383,440 | 386.6 K to 383.4 K (-0.81 %) |
Sep 16 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 50.06 | 1,000 | 50,064 | 386,562 | 387.6 K to 386.6 K (-0.26 %) |
Sep 16 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 50.00 | 111 | 5,550 | 387,562 | 387.7 K to 387.6 K (-0.03 %) |
Jul 09 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 50.00 | 5,000 | 250,000 | 387,673 | 392.7 K to 387.7 K (-1.27 %) |
Jul 01 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Buy | J | 0.00 | 1,088 | 0 | 392,673 | 391.6 K to 392.7 K (+0.28 %) |
Jun 05 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 50.00 | 5,000 | 250,000 | 391,585 | 396.6 K to 391.6 K (-1.26 %) |
Jun 05 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Gift | G | 0.00 | 1,020 | 0 | 396,585 | 397.6 K to 396.6 K (-0.26 %) |
Jun 05 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Gift | G | 0.00 | 1,020 | 0 | 397,605 | 398.6 K to 397.6 K (-0.26 %) |
Jun 05 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Grant | A | 41.57 | 444 | 18,459 | 3,294 | 2.9 K to 3.3 K (+15.58 %) |
Jun 01 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 50.00 | 5,000 | 250,000 | 398,625 | 403.6 K to 398.6 K (-1.24 %) |
Apr 27 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 50.00 | 2,153 | 107,650 | 403,625 | 405.8 K to 403.6 K (-0.53 %) |
Apr 27 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 50.00 | 2,847 | 142,350 | 405,778 | 408.6 K to 405.8 K (-0.70 %) |
Mar 04 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 51.57 | 10,000 | 515,706 | 408,625 | 418.6 K to 408.6 K (-2.39 %) |
Feb 19 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 54.00 | 10,000 | 540,000 | 418,625 | 428.6 K to 418.6 K (-2.33 %) |
Feb 19 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Gift | G | 0.00 | 1,632 | 0 | 428,625 | 430.3 K to 428.6 K (-0.38 %) |
Jan 16 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 55.00 | 3,580 | 196,900 | 430,257 | 433.8 K to 430.3 K (-0.83 %) |
Jan 16 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 55.01 | 6,420 | 353,172 | 433,837 | 440.3 K to 433.8 K (-1.46 %) |
Jan 09 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Gift | G | 0.00 | 100 | 0 | 440,257 | 440.4 K to 440.3 K (-0.02 %) |
Jan 09 2020 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Gift | G | 0.00 | 170 | 0 | 440,357 | 440.5 K to 440.4 K (-0.04 %) |
Dec 05 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 58.90 | 10,000 | 589,048 | 440,527 | 450.5 K to 440.5 K (-2.22 %) |
Dec 05 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Gift | G | 0.00 | 1,000 | 0 | 450,527 | 451.5 K to 450.5 K (-0.22 %) |
Nov 27 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 56.52 | 10,000 | 565,218 | 451,527 | 461.5 K to 451.5 K (-2.17 %) |
Nov 19 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 50.26 | 10,000 | 502,574 | 471,527 | 481.5 K to 471.5 K (-2.08 %) |
Nov 19 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 46.45 | 900 | 41,805 | 481,527 | 482.4 K to 481.5 K (-0.19 %) |
Nov 19 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 45.51 | 2,100 | 95,567 | 482,427 | 484.5 K to 482.4 K (-0.43 %) |
Nov 19 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 44.88 | 2,000 | 89,757 | 484,527 | 486.5 K to 484.5 K (-0.41 %) |
Oct 16 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 36.71 | 2 | 73 | 486,527 | 486.5 K to 486.5 K (0.00 %) |
Oct 16 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 36.16 | 4,998 | 180,744 | 486,529 | 491.5 K to 486.5 K (-1.02 %) |
Sep 18 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 45.74 | 5,000 | 228,722 | 491,527 | 496.5 K to 491.5 K (-1.01 %) |
Aug 19 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 39.01 | 2,780 | 108,445 | 496,527 | 499.3 K to 496.5 K (-0.56 %) |
Aug 19 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 38.36 | 2,220 | 85,151 | 499,307 | 501.5 K to 499.3 K (-0.44 %) |
Jul 17 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 40.04 | 15,000 | 600,561 | 501,527 | 516.5 K to 501.5 K (-2.90 %) |
Jul 17 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Grant | A | 12.01 | 1,769 | 21,247 | 2,850 | 1.1 K to 2.9 K (+163.64 %) |
May 06 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 25.03 | 5,000 | 125,150 | 521,527 | 526.5 K to 521.5 K (-0.95 %) |
May 03 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 25.30 | 3,892 | 98,468 | 526,527 | 530.4 K to 526.5 K (-0.73 %) |
May 03 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 26.01 | 1,108 | 28,819 | 530,419 | 531.5 K to 530.4 K (-0.21 %) |
May 03 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Grant | A | 12.01 | 1,081 | 12,983 | 1,081 | 0 to 1.1 K |
Apr 16 2019 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Sell | S | 23.11 | 5,000 | 115,550 | 531,527 | 536.5 K to 531.5 K (-0.93 %) |
Nov 07 2018 | EIDX | Eidos Therapeutics ... | Fox Jonathan C | See Remarks | Option Exercise | A | 13.20 | 70,000 | 924,000 | 70,000 | |
May 06 2016 | MYOK | MyoKardia Inc | Fox Jonathan C | Chief Medical Offic ... | Grant | A | 8.50 | 1,807 | 15,360 | 240,997 | 239.2 K to 241 K (+0.76 %) |
Nov 05 2015 | MYOK | MyoKardia Inc | Fox Jonathan C | Chief Medical Offic ... | Buy | P | 10.00 | 3,000 | 30,000 | 239,190 | 236.2 K to 239.2 K (+1.27 %) |
Page: 1